News | December 12, 2022
Entod Pharmaceuticals to launch GLO division
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
As a result, Imago will become a subsidiary of Merck.
Company to open new headquarters in 2024
The plant, to be built in the Incheon Free Economic Zone in Songdo, Incheon, will be a facility for the manufacture of products such as sterile bags, cell culture media and membrane filters
Anandiben Patel, Governor, Uttar Pradesh will inaugurate the two-day celebrations
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
Subscribe To Our Newsletter & Stay Updated
